AVERY W CATLIN
CIK 1255348 · Sr. VP & CFO · last filed 2024-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.0K
Companies
3
Total Filings
48
Lifetime Open-Market Net
$196.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRBP | Director | 4,350 | $8.74 | $38.0K | $146.3K | 16 | 2024-06-03 |
| Provention Bio, Inc. (PRVB) Delisted | Director | 10,000 | $24.98 | $249.8K | $50.2K | 9 | 2023-04-27 |
| Celldex Therapeutics, Inc. (AVAND) Delisted | Sr. VP & CFO | — | — | — | $0 | 1 | 2008-03-11 |
Recent Filings · Page 5 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-09-09 | — | Buy (P) | +2,000 | $7.0K | |
| 2010-01-22 | — | Grant (A) | — | $0 | |
| 2009-12-01 | — | Buy (P) | +1,000 | $4.4K | |
| 2009-01-08 | — | Grant (A) | +5,868 | $0 | |
| 2009-01-05 | — | L | +100 | $673 | |
| 2008-03-11 | Celldex Therapeutics, Inc. (AVAND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-02 | — | L | +500 | $353 | |
| 2007-01-08 | — | Grant (A) | — | $0 |
Showing 41–48 of 48
Prev
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.